Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance

Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population

(2011) R. Cui et al.   GUT

Src Family Kinase Inhibitor Saracatinib (AZD0530) Impairs Oxaliplatin Uptake in Colorectal Cancer Cells and Blocks Organic Cation Transporters

(2010) C. J. Morrow et al.   CANCER RESEARCH

Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy

(2009) Dirk Theile et al.   BIOCHEMICAL PHARMACOLOGY

Expression of Human Organic Cation Transporter 3 in Kidney Carcinoma Cell Lines Increases Chemosensitivity to Melphalan, Irinotecan, and Vincristine

(2009) Volodymyr Shnitsar et al.   CANCER RESEARCH

Interaction of beta-blockers with the renal uptake transporter OCT2

(2009) I. Bachmakov et al.   DIABETES OBESITY & METABOLISM

Interaction of Imatinib with Human Organic Ion Carriers

(2008) S. Hu et al.   CLINICAL CANCER RESEARCH

Significance of Organic Cation Transporter 3 (SLC22A3) Expression for the Cytotoxic Effect of Oxaliplatin in Colorectal Cancer

(2008) S. Yokoo et al.   DRUG METABOLISM AND DISPOSITION

Pharmacologic markers and predictors of responses to imatinib therapy in patients with chronic myeloid leukemia

(2008) Richard E. Clark et al.   LEUKEMIA & LYMPHOMA

cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects

(2008) Katherine S. Lovejoy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA